Tina Guanting Qiu
I am founder/CEO and inventor, pioneering in big data for IP and medicine innovation, we have a Phase 3 patented molecule for curing glaucoma blindness, currently look for Series A to develop a patented new formulation for clinical trials.
Boston, Massachusetts, US
About Tina
I am retinal surgeon, stem cell biologist and ocular transplant specialist by trainings, I have over 25-years of international experience in leading and advising some of the most exciting ophthalmic product development from stem cell and gene therapy to drug discovery and delivery across all broad industry ( GSK, Inotek Pharma, Lineage Cells, Astellas Pharma). Recently I pioneered in big data for medicine innovation solving the most difficutl problem that is the 90% drug failure at billion $ cost over a decade of development. From big data I discovered the first curative solution for treating glaucoma blindness with a new approach, this is a breakthrough therapy with anticipated high success. OTI-2024 represents the best in class MMP platform therapy.. Here is our website: http://ophthalmic-innovation.com.
Company
Ophthalmic Therapeutic Innovation LLC
ophthalmic-innovation.com
Funding Stage
Series A
Funding Raised
1-5 employees
Team Size
1-5 employees
Annual Revenue
Undisclosed
Founded
2023
Industry
Healthcare
Skills
Founder/CEO
Founded Ophthalmic Therapeutic Innovation LLC and developed a patented molecule for curing glaucoma blindness.
Big Data in Medicine
Pioneered the use of big data for medical innovation, specifically in drug discovery and delivery.
Pioneered Breakthrough Therapy
Discovered a curative solution for treating glaucoma blindness, representing a breakthrough in therapy.
Ophthalmology Product Development
Over 25 years of experience in leading and advising ophthalmic product development, including stem cell and gene therapy.
Healthcare
Extensive experience in the healthcare industry, particularly in ophthalmology.
Experience
job
Ophthalmic Product Development Advisor
GSK
Advised on the development of ophthalmic products, focusing on innovative therapies and drug delivery systems.
Contributed to the development of several key ophthalmic products during tenure.
job
Research Director
Lineage Cells
Directed research initiatives focused on stem cell therapies for eye diseases.
Pioneered research that led to significant advancements in ocular transplant techniques.
job
Consultant
Astellas Pharma
Provided consulting services on ophthalmic product development and regulatory strategies.
Advised on successful product launches and regulatory approvals in the ophthalmic sector.
job
Founder/CEO
Ophthalmic Therapeutic Innovation LLC
Leading the company in developing innovative therapies for glaucoma blindness using big data and patented formulations.
Successfully developed a Phase 3 patented molecule for curing glaucoma blindness and currently seeking Series A funding for clinical trials.
job
Senior Scientist
Inotek Pharma
Led research projects in stem cell and gene therapy for ophthalmic applications.
Developed novel approaches to drug discovery and delivery in ophthalmology.